Summary
For Year 2026-27, Advanced Enzyme Technologies reports the following shareholding: Total Promoters at 43.26%, Mutual Fund at 1.93%, Insurance at 0%, Foreign Institutional Investors at 25.5%, Domestic Institutional Investors at 3.47%, and Retail at 25.84%. This breakdown provides a quick snapshot of ownership distribution for Advanced Enzyme Technologies in 2026-27.
Advanced Enzyme Technologies FAQs
As of 04-2026, the promoter shareholding in Advanced Enzyme Technologies stands at 43.26% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Advanced Enzyme Technologies is 25.5% and 3.47% respectively.
The retail shareholding of the Advanced Enzyme Technologies is 25.84%.
Changes in shareholding patterns of Advanced Enzyme Technologies can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Advanced Enzyme Technologies are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Advanced Enzyme Technologies Associated Pages
- Advanced Enzyme Technologies Share Price
- Advanced Enzyme Technologies Share Price chart
- Advanced Enzyme Technologies Fundamental Analysis
- Advanced Enzyme Technologies Technical Analysis
- Advanced Enzyme Technologies Peer Comparison
- Advanced Enzyme Technologies Share Price History
- Advanced Enzyme Technologies Dividend
- Advanced Enzyme Technologies Board of Directors
